rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG) Peptid
Kurzübersicht für rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG) Peptid (ABIN8110477)
Target
Quelle
Applikation
-
-
Verwendungszweck
- ARHGDIG Peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-ARHGDIG antibody ( ARP33854_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- ARHGDIG (rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG))
-
Hintergrund
-
Background Information: ARHGDIG is highly expressed in the entire brain, with regional variations. The mRNA is also present at high levels in kidney and pancreas and at moderate levels in spinal cord, stomach, and pituitary gland. ARHGDIG is mapped to chromosome band 16p13.3 which is rich in deletion mutants of genes involved in several human diseases, notably polycystic kidney disease, alpha-thalassemia, tuberous sclerosis, mental retardation, and cancer.
Alternative Symbols: RHOGDI-3
-
Molekulargewicht
- 25kDa
-
Gen-ID
- 398
-
NCBI Accession
- NP_001167
-
UniProt
- Q99819
Target
-
